Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / B••••••••• I••••••••

B••••••••• I••••••••

Multi-stage venture firmWellesley, MAb•••••••••.comSEC venture capital fund adviser

BioVentures MedTech Funds is committed to the innovators who are changing the practice of medicine. BioVentures MedTech Funds invests in companies that are developing today’s leading-edge medical technologies, finding the dynamic solutions that improve healthcare outcomes worldwide.BioVentures MedTech Funds invests in the future of healthcare.

both early and growth/opportunity families, reported GAV $305M

Importance
43
elevated
Active deployment
26
moderate
Emerging
0
low
Completeness
75
high
Freshness
99
high
Research priority
12
low
Identity and regulatory footprint
Headquarters
Westborough, MAadviserinfo.sec.gov
Office address
2200 WEST PARK DRIVE, SUITE 300, Westborough, MA, 01581adviserinfo.sec.gov
Business phone
617-252-3443adviserinfo.sec.gov
Website
b•••••••••.com
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 26, 2026
Private funds reported
6 (6 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$303Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
B•• I••• L•• (General Partner Of B••••••••• I•••••••• Iii Management L•••••• P•••••••••), E
business email
info@bioventuresinvestors.combioventuresinvestors.compublished by the subject
business phone
617-252-3443adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
7 observed deals
Stated (the firm’s website)
Sectors
healthcare, medtech
Stages
growth
Geography
worldwide
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 7
Funds and vehicles
7 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
B••••••••• I•••••••• M•••••• G••••• C•••••• L•Growth fund2020 form d first saleMature$206M
Mar 27, 2024
4$205M
of $350M
Dec 1, 2022
B••••••••• I•••••••• ••••••••• I• L•••••• P•••••••••Feeder or parallel2015 adv first reportedHarvest$45.0M
Mar 27, 2024
8unknownunknown
B••••••••• I•••••••• I• L•••••• P•••••••••Fund2015 form d first saleHarvest$27.2M
Mar 27, 2024
36$29.4M
of $100M
Aug 4, 2016
B••••••••• I•••••••• I•• L•••••• P•••••••••FundunknownUnknown$14.4M
Mar 27, 2024
76unknownunknown
B••••••••• I•••••••• L•••••• P••••••••• I•FundunknownUnknown$7.6M
Mar 27, 2024
78unknownunknown
B••••••••• I•••••••• ••••••••• I•• L•Feeder or parallelunknownUnknown$2.8M
Mar 27, 2024
12unknownunknown
B••••••••• I•••••••• L•••••• P•••••••••FundunknownUnknown$1.2M
Mar 29, 2017
99unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
20 current, 0 departed
M••• G•••••••
CO-FOUNDER AND MANAGING PARTNER
Managing partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
J•••• L•••••••••
Shareholder · since Jan 1, 2017
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
J••••••• P•••• G••••••
Managing Director Of B••••••••• M•••••• G••••• Capital Management Llc · since Dec 1, 2020
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
M••• E••• G•••••••
Managing Director Of B••••••••• I•••••••• Llc · since Jan 1, 1999
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
M••• E••• G•••••••
Managing Director Of B••••••••• M•••••• G••••• Capital Management Llc · since Dec 1, 2020
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
P•••• L••••••• F••••••••
Member Of B••••••••• I•••••••• Iv Management Llc · since Feb 1, 2017
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
P•••• L••••••• F••••••••
Managing Director Of B••••••••• I•••••••• Llc · since Jan 1, 1999
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
T••• L••••
MANAGING DIRECTOR - INVESTOR DEVELOPMENT
Partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Partner
FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
L•••• N•••••••
VENTURE PARTNER AND PRINCIPAL
Venture partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
P•••• F••••••••
CO-FOUNDER AND VENTURE PARTNER
Venture partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture partner
FactVenture organization websites (about, team, portfolio, thesis, news pages)
Investments on record
7 edges, 7 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
B•••••••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
C•••••••••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
C•••••••••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
O••••••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
S••• M•••••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
U•• I••••••••• S••••••••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
V•••• B•••••••••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
2 relationships from shared deals, counted for the whole firm
Genoa Ventures, LLC 1 shared · one timeKickstart Capital, LLC 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
12 dated events
  1. Mar 31, 2021
    B••••••••• I•••••••• M•••••• G••••• C•••••• L• first reported on Form ADV by B••••••••• I•••••••• (Venture Capital Fund), GAV $206,502,864
    Fund first reported on Form ADVFundsFactB••••••••• I•••••••• M•••••• G••••• C•••••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  2. Dec 1, 2020
    J••••••• P•••• G•••••• joined Schedule A of B••••••••• I•••••••• as Managing Director Of B••••••••• M•••••• G••••• Capital Management Llc
    Person joinedPeopleFactJ••••••• P•••• G••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  3. Feb 1, 2017
    J•••• L••••••••• joined Schedule A of B••••••••• I•••••••• as Managing Director Of B••••••••• I•••••••• Iv Management Llc
    Person joinedPeopleFactJ•••• L•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  4. Mar 31, 2015
    B••••••••• I•••••••• I• L•••••• P••••••••• first reported on Form ADV by B••••••••• I•••••••• (Venture Capital Fund), GAV $19,333,333
    Fund first reported on Form ADVFundsFactB••••••••• I•••••••• I• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  5. Mar 31, 2015
    B••••••••• I•••••••• ••••••••• I• L•••••• P••••••••• first reported on Form ADV by B••••••••• I•••••••• (Venture Capital Fund), GAV $4,000,000
    Fund first reported on Form ADVFundsFactB••••••••• I•••••••• ••••••••• I• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  6. Jan 1, 2015
    J•••••• T••••• B••••• joined Schedule A of B••••••••• I•••••••• as Managing Director Of B••••••••• I•••••••• Iv Management Llc
    Person joinedPeopleFactJ•••••• T••••• B•••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  7. Mar 26, 2012
    B••••••••• I•••••••• L•••••• P••••••••• first reported on Form ADV by B••••••••• I•••••••• (Venture Capital Fund), GAV $2,531,556
    Fund first reported on Form ADVFundsFactB••••••••• I•••••••• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  8. Mar 26, 2012
    B••••••••• I•••••••• first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  9. Mar 26, 2012
    B••••••••• I•••••••• L•••••• P••••••••• I• first reported on Form ADV by B••••••••• I•••••••• (Venture Capital Fund), GAV $16,421,778
    Fund first reported on Form ADVFundsFactB••••••••• I•••••••• L•••••• P••••••••• I•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  10. Mar 26, 2012
    B••••••••• I•••••••• I•• L•••••• P••••••••• first reported on Form ADV by B••••••••• I•••••••• (Venture Capital Fund), GAV $30,547,134
    Fund first reported on Form ADVFundsFactB••••••••• I•••••••• I•• L•••••• P•••••••••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  11. Mar 26, 2012
    B••••••••• I•••••••• ••••••••• I•• L• first reported on Form ADV by B••••••••• I•••••••• (Venture Capital Fund), GAV $6,057,497
    Fund first reported on Form ADVFundsFactB••••••••• I•••••••• ••••••••• I•• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
  12. Mar 26, 2012
    B••••••••• I•••••••• first filed Form ADV (ERA, venture capital fund adviser exemption)
    First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
  1. Sep 15, 2026
    Multi-stage venture firm (confirmed, 95%, cls-1)
    both early and growth/opportunity families, reported GAV $305M
  2. Sep 12, 2026
    Multi-stage venture firm (confirmed, 95%, cls-1)
    both early and growth/opportunity families, reported GAV $303M
Evidence
77 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-26Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-26Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-03-26Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-03-27Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2017-03-29Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC statusERA - ActiveMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC status effective2012-03-26Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone617-252-3443Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone617-252-3443Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone617-252-3443Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://b•••••••••.com/
“contact page linked from the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionBioVentures MedTech Funds is committed to the innovators who are changing the practice of medicine. BioVentures MedTech Funds invests in companies that are developing today’s leading-edge medical technologies, finding the dynamic solutions that improve healthcare outcomes worldwide.BioVentures MedTech Funds invests in the future of healthcare.
“meta description”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionBioVentures MedTech Funds is committed to the innovators who are changing the practice of medicine. BioVentures MedTech Funds invests in companies that are developing today’s leading-edge medical technologies, finding the dynamic solutions that improve healthcare outcomes worldwide.BioVentures MedTech Funds invests in the future of healthcare.
“meta description”
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersWestborough, MAMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersMarlborough, MAMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersWellesley, MAMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address2200 WEST PARK DRIVE, SUITE 300, Westborough, MA, 01581Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address148 BARTLETT STREET, Marlborough, MA, 01752Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address70 WALNUT STREET SUITE 302, Wellesley, MA, 02481Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formCorporationMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formCorporationMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formCorporationMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://b•••••••••.com/
“7 entries read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://b•••••••••.com/
“7 entries read”
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported6Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported6Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported1Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$303MMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$303MMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$1.2MMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyworldwide
“geography words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyworldwide
“geography words on the home page”
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,medtech
“sector words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,medtech
“sector words on the home page”
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesgrowth
“stage words on the home page”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesgrowth
“stage words on the home page”
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://b•••••••••.com/
“12 name/title pairs read”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://b•••••••••.com/
“12 name/title pairs read”
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported6Mar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported6Mar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture funds reported1Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://w••.b•••••••••.comMar 26, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
WebsiteHTTP://w••.b•••••••••.comMar 27, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://w••.b•••••••••.comMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleBioVentures MedTech Funds
“title tag”
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleBioVentures MedTech Funds
“title tag”
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)